Biora Therapeutics Overview
- Year Founded
-
2010
- Status
-
Public
- Employees
-
58
- Stock Symbol
-
BIORQ
- Investments
-
5
Biora Therapeutics General Information
Description
Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.
Contact Information
Website
www.bioratherapeutics.comCorporate Office
- 10070 Carroll Canyon Road
- Suite 100
- San Diego, CA 92131
- United States
Corporate Office
- 10070 Carroll Canyon Road
- Suite 100
- San Diego, CA 92131
- United States
Biora Therapeutics Timeline
Biora Therapeutics Stock Performance
As of 10-Nov-2026, Biora Therapeutics’s current market cap is $5.00.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $5.00 | 644.88 |
Biora Therapeutics Financials Summary
As of 30-Sep-2024, Biora Therapeutics has a trailing 12-month revenue of $892K.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 59,929 | 106,555 | 121,658 | 445,474 |
| Revenue | 892 | 4 | 305 | 1,247 |
| EBITDA | (27,965) | (114,054) | (37,353) | (164,567) |
| Net Income | (31,539) | (124,115) | (38,157) | (247,412) |
| Total Assets | 14,505 | 31,215 | 53,525 | 108,839 |
| Total Debt | 39,646 | 47,426 | 129,305 | 126,404 |
Biora Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Biora Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Biora Therapeutics Comparisons
Industry
Financing
Details
Biora Therapeutics Competitors (28)
One of Biora Therapeutics’s 28 competitors is Regenxbio, a Formerly VC-backed company based in Rockville, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Regenxbio | Formerly VC-backed | Rockville, MD | ||||
| Renova Therapeutics | Venture Capital-Backed | Carlsbad, CA | ||||
| Benitec Biopharma | Corporation | Hayward, CA | ||||
| ElevateBio | Venture Capital-Backed | Waltham, MA | ||||
| BioMarin Pharmaceutical | Formerly PE-Backed | San Rafael, CA |
Biora Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Biora Therapeutics Patents
Biora Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4770724-A1 | Ingestible drug delivery device | Pending | 01-Sep-2023 | ||
| WO-2025050006-A1 | Ingestible drug delivery device | Inactive | 01-Sep-2023 | ||
| US-20250195855-A1 | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract | Pending | 18-Mar-2022 | ||
| WO-2023178354-A1 | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract | Inactive | 18-Mar-2022 | ||
| CA-3226564-A1 | Aqueous formulations of tofacitinib and tofacitinib salts | Pending | 09-Sep-2021 | A61K9/0095 |
Biora Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Biora Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Biora Therapeutics Investments & Acquisitions (5)
Biora Therapeutics’s most recent deal was a Early Stage VC with Enumera Molecular for . The deal was made on 16-Aug-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Enumera Molecular | 16-Aug-2022 | Early Stage VC | Decision/Risk Analysis | ||
| Medimetrics (Intellectual Property Portfolio) | 18-Sep-2019 | Corporate Asset Purchase | Buildings and Property | ||
| Mattison Pathology (Certain Assets) | 01-Jun-2015 | Corporate Asset Purchase | Buildings and Property | ||
| Carmenta Bioscience | 29-Apr-2015 | Merger/Acquisition | Biotechnology | ||
| Interface Therapeutics | 01-Jan-2015 | Merger/Acquisition | Drug Discovery |
Biora Therapeutics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Services
Subindustry
Rank
Percentile
Biora Therapeutics FAQs
-
When was Biora Therapeutics founded?
Biora Therapeutics was founded in 2010.
-
Where is Biora Therapeutics headquartered?
Biora Therapeutics is headquartered in San Diego, CA.
-
What is the size of Biora Therapeutics?
Biora Therapeutics has 58 total employees.
-
What industry is Biora Therapeutics in?
Biora Therapeutics’s primary industry is Drug Delivery.
-
Is Biora Therapeutics a private or public company?
Biora Therapeutics is a Public company.
-
What is Biora Therapeutics’s stock symbol?
The ticker symbol for Biora Therapeutics is BIORQ.
-
What is the current market cap of Biora Therapeutics?
The current market capitalization of Biora Therapeutics is $5.00.
-
What is Biora Therapeutics’s current revenue?
The trailing twelve month revenue for Biora Therapeutics is $892K.
-
Who are Biora Therapeutics’s competitors?
Regenxbio, Renova Therapeutics, Benitec Biopharma, ElevateBio, and BioMarin Pharmaceutical are some of the 28 competitors of Biora Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
